HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niki Katsiki Selected Research

Niki Katsiki Research Topics

Disease

33Non-alcoholic Fatty Liver Disease
06/2022 - 11/2011
33Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2009
33Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2008
22Inflammation (Inflammations)
01/2022 - 01/2010
22Obesity
12/2020 - 10/2008
22Insulin Resistance
11/2020 - 10/2010
20Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 01/2011
18Stroke (Strokes)
11/2022 - 07/2011
15Heart Failure
10/2022 - 09/2012
15Atherosclerosis
01/2021 - 02/2009
14Chronic Renal Insufficiency
01/2020 - 12/2011
13Hypertension (High Blood Pressure)
01/2019 - 10/2008
12Coronary Disease (Coronary Heart Disease)
01/2022 - 04/2012
11Alcoholic Fatty Liver
01/2019 - 08/2012
9Dyslipidemias (Dyslipidemia)
01/2021 - 01/2013
9Coronary Artery Disease (Coronary Atherosclerosis)
09/2018 - 06/2013
8Weight Loss (Weight Reduction)
01/2020 - 06/2011
7COVID-19
01/2022 - 01/2020
6Fatty Liver
01/2022 - 12/2011
6Peripheral Arterial Disease
01/2021 - 12/2017
5Transient Ischemic Attack
04/2022 - 01/2017
5Diabetes Mellitus
01/2022 - 01/2015
5Neoplasms (Cancer)
08/2020 - 09/2018
5Vascular Diseases (Vascular Disease)
07/2018 - 01/2016
5Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2017 - 07/2009
5Body Weight (Weight, Body)
01/2017 - 12/2010
4Hyperglycemia
08/2021 - 12/2010
4Thrombosis (Thrombus)
02/2021 - 07/2018
4Diabetes Complications
02/2020 - 01/2014
3Metabolic Diseases (Metabolic Disease)
12/2021 - 01/2014
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2021 - 01/2018
3Myocardial Infarction
11/2020 - 06/2013
3Chronic Disease (Chronic Diseases)
08/2020 - 06/2011
3Atherosclerotic Plaque (Atheroma)
11/2019 - 07/2010
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2018 - 07/2013
3Carotid Artery Diseases
07/2018 - 07/2013
3Overweight
02/2015 - 01/2010
3Acute Coronary Syndrome
02/2015 - 12/2011
3Obstructive Sleep Apnea
01/2014 - 01/2014
2Cardiomyopathies (Cardiomyopathy)
10/2022 - 01/2021
2Hemorrhage
04/2022 - 01/2022
2Brain Infarction
04/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

44Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 07/2010
36LipidsIBA
04/2022 - 12/2010
18Glucose (Dextrose)FDA LinkGeneric
01/2020 - 10/2008
16Uric Acid (Urate)IBA
12/2021 - 11/2011
15Insulin (Novolin)FDA Link
08/2021 - 10/2008
14Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2013
10Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 12/2010
9oxidized low density lipoproteinIBA
01/2022 - 10/2010
8AdipokinesIBA
07/2018 - 11/2011
7HDL CholesterolIBA
01/2022 - 04/2012
7C-Reactive ProteinIBA
01/2022 - 10/2014
7Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2011
7Glucagon-Like Peptide 1 (GLP 1)IBA
11/2021 - 11/2012
7Lipoprotein(a)IBA
05/2021 - 01/2014
7Ezetimibe (Zetia)FDA Link
03/2018 - 10/2010
6LDL CholesterolIBA
01/2022 - 01/2013
6Pioglitazone (Actos)FDA Link
01/2020 - 12/2010
6Pharmaceutical PreparationsIBA
01/2019 - 11/2011
6Atorvastatin (Lipitor)FDA Link
01/2014 - 08/2012
5Lipoproteins (Lipoprotein)IBA
02/2022 - 03/2013
5CytokinesIBA
11/2020 - 07/2013
5empagliflozinIBA
11/2020 - 01/2017
5MicroRNAs (MicroRNA)IBA
01/2020 - 01/2014
5AdiponectinIBA
01/2019 - 01/2011
4CholesterolIBA
01/2022 - 12/2011
4Sodium-Glucose Transporter 2 InhibitorsIBA
11/2021 - 01/2016
4AntioxidantsIBA
01/2021 - 02/2009
4SodiumIBA
11/2019 - 01/2016
4EnzymesIBA
01/2019 - 09/2013
4LeptinIBA
07/2018 - 01/2011
4Simvastatin (Zocor)FDA LinkGeneric
01/2014 - 10/2010
3sacubitril and valsartan sodium hydrate drug combinationIBA
10/2022 - 01/2014
3Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2018
3semaglutideIBA
01/2022 - 01/2017
3Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2015
3Apolipoproteins B (ApoB)IBA
01/2020 - 01/2018
3ApolipoproteinsIBA
01/2020 - 02/2015
3Metformin (Glucophage)FDA LinkGeneric
01/2020 - 12/2010
3LiraglutideFDA Link
01/2019 - 01/2016
3Alanine Transaminase (SGPT)IBA
01/2019 - 01/2011
3Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2019 - 01/2010
3Antihypertensive Agents (Antihypertensives)IBA
06/2018 - 01/2014
3VitaminsIBA
12/2017 - 02/2009
3Vitamin DFDA LinkGeneric
02/2017 - 01/2014
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2014 - 01/2013
3Peptides (Polypeptides)IBA
03/2013 - 01/2011
3GhrelinIBA
01/2012 - 01/2011
2CreatinineIBA
12/2022 - 01/2019
2CarbohydratesIBA
06/2022 - 01/2019

Therapy/Procedure

23Therapeutics
10/2022 - 10/2010
6Glycemic Control
01/2018 - 12/2010
5Drug Therapy (Chemotherapy)
01/2020 - 07/2014
4Carotid Endarterectomy
11/2022 - 01/2018
4Percutaneous Coronary Intervention
01/2018 - 08/2011
3Vascular Surgical Procedures
11/2022 - 05/2021
3Secondary Prevention
01/2017 - 02/2009
2Mediterranean Diet
06/2022 - 11/2019
2Blood Component Removal (Apheresis)
02/2022 - 01/2021